Patents Represented by Attorney Janique Forget

Find this attorney in the Justia Lawyer Directory

  • Methods and compositions for modulating tumor cell activity
    Patent number: 8044179
    Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin.
    Type: Grant
    Filed: September 13, 2006
    Date of Patent: October 25, 2011
    Inventors: Maureen D. O'Connor-McCourt, Christiane Cantin, Anne E. G. Lenferink